Investment Overview – Arvinas’s Shares Buoyant As Vepdegestrant / Ibrance Combo Study Initiated I covered the “protein degradation” specialist drug developer Arvinas (NASDAQ:ARVN) in...
By Marianna Parraga HOUSTON/MIAMI (Reuters) -The highest bid received in a U.S. auction of shares that will decide the fate of Venezuela-owned oil refiner...